anacardic acid has been researched along with Breast Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Gnanaprakasam, JNR; López-Bañuelos, L; Vega, L | 1 |
Alizadeh-Rad, N; Green, MA; Klinge, CM; Muluhngwi, P; Rouchka, EC; Schultz, DJ; Waigel, SJ | 1 |
Dora, CP; Gupta, RC; Jain, S; Katiyar, SS; Kumar Agrawal, A; Kushwah, V; Lamprou, DA | 1 |
Ghadi, R; Jain, S; Katiyar, SS; Kushwah, V; Rege, MD | 1 |
Huo, Q; Li, H; Liu, H; Ma, T; Nie, L; Wu, C; Zhao, S | 1 |
Chen, C; Cunningham, AR; Dougherty, SM; Imbert-Fernandez, Y; Isaacs, SM; Ivanova, MM; Klinge, CM; Schultz, DJ; Wickramasinghe, NS | 1 |
6 other study(ies) available for anacardic acid and Breast Neoplasms
Article | Year |
---|---|
Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model.
Topics: Anacardic Acids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Immunity, Cellular; Immunization; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Paclitaxel | 2021 |
Genome-wide miRNA response to anacardic acid in breast cancer cells.
Topics: Anacardic Acids; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cluster Analysis; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genome-Wide Association Study; Humans; MicroRNAs; RNA Interference; RNA, Messenger; Transcriptome | 2017 |
Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Topics: Albumins; Anacardic Acids; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Clathrin; Deoxycytidine; Docetaxel; Drug Carriers; Female; Gemcitabine; Hemolysis; Humans; Macromolecular Substances; MCF-7 Cells; Nanoparticles; Neoplasm Transplantation; Particle Size; Polymers; Protein Conformation; Rats; Rats, Sprague-Dawley | 2018 |
Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy.
Topics: Anacardic Acids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Female; Gelatin; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Surface Properties | 2019 |
[Effect of anacardic acid, a Hsp90 inhibitor, on proliferation, invasion and migration of breast cancer MDA-MB-231 cells].
Topics: Anacardic Acids; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; HSP90 Heat-Shock Proteins; Humans; Matrix Metalloproteinase 9; Tissue Inhibitor of Metalloproteinase-1 | 2015 |
Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
Topics: Anacardic Acids; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Proliferation; DNA; Down-Regulation; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Protein Binding; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2010 |